{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:09:10Z","timestamp":1791421750324,"version":"4.3.3"},"reference-count":21,"publisher":"Health Affairs Publishing, LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Health Affairs"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1377\/hlthaff.27.4.1042","type":"journal-article","created":{"date-parts":[[2008,7,7]],"date-time":"2008-07-07T20:42:24Z","timestamp":1215463344000},"page":"1042-1050","source":"Crossref","is-referenced-by-count":144,"title":["Pharmaceutical Policy In China"],"prefix":"10.1377","volume":"27","author":[{"given":"Qiang","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyue","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Eggleston","sequence":"additional","affiliation":[{"name":"Center for Health Management and Policy, Shandong University, in Jinan, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"102","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1002\/hec.1306"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhealeco.2007.08.005"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhealeco.2007.08.005"},{"key":"R7","unstructured":"State Food and Drug Administration South Pharmaceutical Economic Institute, \u201cThe Competition of the Top 100 Pharmaceutical Industries Is Challenging\u201d (in Chinese),\n                      Medicine Economic News\n                      , 10 August           2007           ."},{"key":"R8","unstructured":"B. Chen            and H. Wang, \u201cChina\u2019s Pharmaceutical Industry: Competitive Features, Marketing Conditions, and Development Strategy\u201d (in Chinese),\n                      China Pharmacy\n                      13\n                      , no. 5 (           2002           ):           260           \u2013262."},{"key":"R9","unstructured":"D. Jiang            and J. Zhang, \u201cThe Consideration of the Development of GMP in China\u201d (in Chinese),\n                      Chinese Pharmaceutical Management\n                      20\n                      , no. 4 (           2006           ):           44           \u201347."},{"key":"R12","unstructured":"Y. Zhang            , \u201cThe Current Situation and Future of the Pharmaceutical Distribution System in China,\u201d\n                      Economic Theory and Management\n                      3\n                      , no. 1 (           2005           ):           34           \u201338."},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1007\/s10754-006-5558-5"},{"key":"R14","unstructured":"Y. Liang            , \u201cDrug Representatives Disclose the Rebates Related to the High Drug Prices\u201d (in Chinese),\n                      Xi\u2019an Medical Information\n                      4\n                      , no. 10 (           2005           ):           4           \u20136."},{"key":"R15","unstructured":"Q. Wang            and J. Qiu, \u201cDiscussion and Research on Medicine Price Reform in China\u201d (in Chinese),\n                      China Pharmacy\n                      17\n                      , no. 22 (           2006           ):           1684           \u20131687."},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.06.033647"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/15.2.157"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/15.2.157"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/czi018"},{"key":"R26","unstructured":"D. Du            , \u201cDifficulties for Costing Pharmaceuticals,\u201d\n                      Price Theory and Practice\n                      3\n                      , no. 3 (           2002           ):           10           \u201311"},{"key":"R26","unstructured":"; and            Q. Wang            and J. Wei, \u201cThe Causes of and Solutions to Unreasonable Drug Prices\u201d (in Chinese),\n                      Journal of Lanzhou Commercial College\n                      19\n                      , no. 2 (           2003           ):           98           \u201398."},{"key":"R28","unstructured":"L. Zhang            , \u201cAnalysis of Reasons for Revenue Loss and Discussion of Countermeasures for General Hospital Pharmacies\u201d (in Chinese),\n                      Chinese Hospital Management\n                      23\n                      , no. 9 (           2003           ):           45           \u201347."},{"key":"R29","unstructured":"X. Liu            and A. Mills, \u201cThe Influence of Bonus Payments to Doctors on Hospital Revenue: Results of a Quasi-Experimental Study,\u201d\n                      Applied Health Economics and Health Policy\n                      2\n                      , no. 2 (           2003           ):           91           \u201398"},{"key":"R29","unstructured":"; and            K. Eggleston            et al. \u201cPhysician Payment Incentives, Cost, and Quality of Hospital Services: Evidence from Guangdong, China,\u201d\n                      China Labor Economics\n                      (forthcoming)."},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1177\/004947559802800112"},{"key":"R31","unstructured":"W. Cheng            , \u201cThe Analysis of the Characteristics and Defects of China\u2019s Pharmaceutical Price System\u201d (in Chinese),\n                      Shanghai Pharmaceuticals\n                      26\n                      , no. 12 (           2005           ):           533           \u2013535."}],"container-title":["Health Affairs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.healthaffairs.org\/doi\/10.1377\/hlthaff.27.4.1042","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T15:02:41Z","timestamp":1664290961000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.healthaffairs.org\/doi\/10.1377\/hlthaff.27.4.1042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["10.1377\/hlthaff.27.4.1042"],"URL":"https:\/\/doi.org\/10.1377\/hlthaff.27.4.1042","relation":{},"ISSN":["0278-2715","1544-5208"],"issn-type":[{"value":"0278-2715","type":"print"},{"value":"1544-5208","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}